Product description
Brand name
Bamlanivimab and etesevimab
Company name
Eli Lilly Canada Inc
Ingredient
LY-CoV555 / LY-CoV016
Date of approval
Resources
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.